ULBI Ultralife

Ultralife Corporation Receives $14.4 Million IDIQ Award from Defense Logistics Agency for BA-5368 Military Batteries

Ultralife Corporation Receives $14.4 Million IDIQ Award from Defense Logistics Agency for BA-5368 Military Batteries

NEWARK, N.Y., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $14.4 million from the U.S. Government’s Defense Logistics Agency (DLA) for its lithium manganese dioxide, non-rechargeable BA-5368 batteries. These batteries are used in a variety of military applications, including detectors and imaging. The award consists of a three-year base contract with two one-year option periods.  The amounts and timing of deliveries under this contract are at the discretion of the DLA.

“Ultralife is a long-standing supplier to the U.S. military, and our BA-5368 battery is recognized for its long life, high energy density, and proven safety, performance and reliability across a wide temperature range.  We are pleased that DLA has selected Ultralife once again,” said Michael D. Popielec, President and Chief Executive Officer.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit .

Company Contact:                                                                               

Ultralife Corporation                                                                           

Philip A. Fain                                                                                 

(315) 210-6110                                                                     

                                                                             

Investor Relations Contact:    

LHA 

Jody Burfening 
        

(212) 838-3777          

 

EN
19/09/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ultralife

 PRESS RELEASE

Ultralife Corporation Reports Fourth Quarter Results

Ultralife Corporation Reports Fourth Quarter Results NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarterGross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarterOperating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of on...

 PRESS RELEASE

Ultralife Corporation to Report Fourth Quarter Results on March 10, 20...

Ultralife Corporation to Report Fourth Quarter Results on March 10, 2026 NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday, March 10, 2026. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on March 10, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch